BIVRX BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES

USD 18.26 0.00 0
Icon

BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES (BIVRX) Stock Analysis and Price Targets

FUND | Others | NMF
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 18.26

0.00 (0.00)%

N/A

N/A

N/A

N/A

Icon

BIVRX

BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES (USD)
FUND | NMF
USD 18.26
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

N/A

N/A

USD 18.26

BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES (BIVRX) Stock Forecast

N/A

Based on the BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES stock forecast from 0 analysts, the average analyst target price for BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES is not available over the next 12 months. BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES is Slightly Bearish, which is based on 1 positive signals and 2 negative signals. At the last closing, BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES’s stock price was USD 18.26. BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES’s stock price has changed by +0.44% over the past week, +2.13% over the past month and -20.09% over the last year.

No recent analyst target price found for BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES
No recent average analyst rating found for BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES

Company Overview BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES

The fund invests primarily in both long and short positions in equity securities principally traded in United States markets. Under normal market conditions, the Sub-Adviser seeks to be fully invested in the long portfolio (greater than 80%), while allowing the size of the short ...Read More

N/A

N/A

N/A

N/A

USD

USA

Adjusted Closing Price for BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES (BIVRX)

Loading...

Unadjusted Closing Price for BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES (BIVRX)

Loading...

Share Trading Volume for BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES Shares

Loading...

Compare Performance of BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIVRX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES (Sector: Others )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRGWX
Vanguard Russell 1000 Growth I.. 0.00 (0.00%) USD26.28B N/A N/A

ETFs Containing BIVRX

Symbol Name BIVRX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES (BIVRX) Stock

Stock Target Advisor's fundamental analysis for BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES's stock is Slightly Bearish.

Unfortunately we do not have enough data on BIVRX's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIVRX's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BIVRX's stock to indicate if its overvalued.

The last closing price of BIVRX's stock was USD 18.26.

Unfortunately we do not currently have any market capitalization data for BIVRX's stock.

Unfortunately we do not have enough analyst data on BIVRX's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES's stock.

Sorry, we do not have any data on the number of employees for BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES.

Sorry we do not have any infomation available on BALTER INVENOMIC FUND BALTER INVENOMIC FUND INVESTOR CLASS SHARES's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...